ClinicalTrials.Veeva

Menu

Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases

H

Heidelberg University

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Colorectal Liver Metastases

Treatments

Radiation: one time radiation
Radiation: No Radiation

Study type

Interventional

Funder types

Other

Identifiers

NCT01191632
S081/2008

Details and patient eligibility

About

The efficiency of T cell based immunotherapies is affected by the insufficient migration and activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical trial is to evaluate whether a neoadjuvant, low dose radiotherapy can improve T cell connected anti tumor immune response in colorectal liver metastases.

The primary endpoint is the number of tumor infiltrating T cells. Furthermore the T cell activity in situ, the number of regulatory T cells and the frequency of tumor reactive T cells in the blood and bone marrow will be examined.

Enrollment

40 estimated patients

Sex

All

Ages

50 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability of subject to understand character and individual consequences of the clinical trial
  • Written informed consent (must be available before enrolment in the trial)
  • Age ≥ 50 years
  • Radiological urgently suspected colorectal liver metastasis

Exclusion criteria

  • second malignancy
  • Pregnancy and lactation
  • no prior liver radiation
  • liver metastasis must be resectable

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 4 patient groups

Radiation 0,5Gy
Active Comparator group
Description:
Radiation: one time Radiation with an intensity of 0.5 Gy Group A Beginning on a weekday 48 hours before surgery
Treatment:
Radiation: one time radiation
No radiation
Active Comparator group
Description:
Control group with 0Gy radiation
Treatment:
Radiation: No Radiation
Radiation 2Gy
Active Comparator group
Description:
Radiation: one time Radiation with an intensity of 2.0 Gy Group B Beginning on a weekday 48 hours before surgery
Treatment:
Radiation: one time radiation
Radiation 5Gy
Active Comparator group
Description:
Radiation: one time Radiation with an intensity of 5 Gy Group C Beginning on a weekday 48 hours before surgery
Treatment:
Radiation: one time radiation

Trial contacts and locations

1

Loading...

Central trial contact

Christoph Reissfelder, MD; Juergen Weitz, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems